Diagnostic and Prognostic Value of Glycated Hemoglobin (HbA1c) in Patients with Diabetes Mellitus and Thalassemia
Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia, which is caused by impaired insulin secretion, insulin action, or both. Four complications of DM have been identified – diabetes microangiopathy including nephropathy, retinopathy and polyneuropathy and diabetes macroangio...
Main Authors: | Yordanov E., Hristov E., Parvova I., Petkova V., Andreevska K. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-09-01
|
Series: | Acta Medica Bulgarica |
Subjects: | |
Online Access: | https://doi.org/10.2478/amb-2020-0027 |
Similar Items
-
Low HbA1c With Normal Hemoglobin in a Diabetes Patient Caused by PIEZO1 Gene Variant: A Case Report
by: An Song, et al.
Published: (2020-06-01) -
International guidelines on the study of glycated hemoglobin HbA1c level as a diagnostic criterion for diabetes mellitus and otherdisorders of carbohydrate metabolism
by: Gagik Radikovich Galstyan
Published: (2010-12-01) -
Non-transfusion dependent thalassemia: translating evidence to guidelines
by: Afif R. Harb, et al.
Published: (2014-12-01) -
Changes in HbA2 Levels May Signify Hemoglobin Defects in Infants
by: Pinyaphat Khamphikham, et al.
Published: (2021-08-01) -
HbA2 measurements in β-thalassemia and in other conditions
by: Giovanni Ivaldi, et al.
Published: (2014-09-01)